Any thoughts on today’s investor update ?
I am a bit each way on it -
- Liked what I heard in the main, starting to prioritise Europe again, completing the Magpie study so we can get wider distribution and paediatric use, engaging healthcare professionals, focus on costs and deployment of resources behind commercial execution .
- Disappointed the A team has spent so much time and money to reach a point of getting back to the basics.
We need to see some real progress and quickly or it’s going to be another down raise just around the corner.
I remain a “ HOLD” DYOR
Ann: Retail Entitlement Offer Investor Call Details, page-8
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.0¢ |
Change
-0.015(3.37%) |
Mkt cap ! $48.44M | |||
| Open | High | Low | Value | Volume |
| 44.5¢ | 44.5¢ | 41.5¢ | $118.8K | 278.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1192 | 43.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.0¢ | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| MVP (ASX) Chart |